Related Experiment Videos
An improved method for heterozygote detection of cystinosis, using polymorphonuclear leukocytes
American Journal of Human Genetics
|August 1, 1987
Summary
Detecting cystinosis carriers is improved by measuring polymorphonuclear leukocyte cystine levels. This method enhances accuracy over mixed-leukocyte analysis for identifying heterozygotes of this genetic disorder.
Area of Science:
- Medical Genetics
- Biochemistry
Background:
- Cystinosis is an autosomal recessive disease.
- Current heterozygote detection relies on mixed-leukocyte cystine content measurement.
Purpose of the Study:
- To re-evaluate the accuracy of mixed-leukocyte analysis for cystinosis heterozygote detection.
- To assess if purified polymorphonuclear leukocyte cystine measurement improves detection sensitivity.
Main Methods:
- Blood samples collected from 29 obligate heterozygotes for nephropathic cystinosis, 1 heterozygote for benign cystinosis, and 18 normal individuals.
- Measured cystine content in both mixed-leukocyte preparations and purified polymorphonuclear leukocytes.
Main Results:
- Three heterozygote values overlapped the normal range when using mixed-leukocyte preparations.
- No heterozygote values fell within the normal range when using purified polymorphonuclear leukocytes.
Conclusions:
- Measuring polymorphonuclear leukocyte cystine content is a simpler and more sensitive method for detecting cystinosis heterozygotes.
- This improved sensitivity aids in the accurate identification of carriers for cystinosis.